Is the occurrence of a fragility fracture — where Medicare beneficiaries broke a hip, wrist or shoulder — a missed opportunity to reduce exposure to prescription drugs associated with fracture risk?
Is the occurrence of a fragility fracture — where Medicare beneficiaries broke a hip, wrist or shoulder — a missed opportunity to reduce exposure to prescription drugs associated with fracture risk?